The virtual nurses can provide conversation for patients who can’t sleep at 2 a.m. or facilitate video calls for out-of-state ...

Work by cancer patients featured in "Art for Recovery" is on view at the San Francisco Museum of Modern Art in the first show of patient art at a major metropolitan museum.

Ocampo will expand research to advance WoundVision’s position as the leader in pressure injury prevention, POA ...

– Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market ...

The MarketWatch News Department was not involved in the creation of this content. -- Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

HORSHAM, Pa., Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), ...

RYBREVANT FASPRO™, the first and only subcutaneous therapy for patients with EGFR-mutated NSCLC, reduces administration time from hours to minutes and significantly reduces administration-related ...

GRAND FORKS — Students at the University of North Dakota School of Medicine and Health Science’s Simulation Center often practice on lifelike mannequins, but another program brings real people into ...

CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a ...

Boston, MA: November 10, 2025 –DASCO Home Medical Equipment has formed a joint venture with Mass General Brigham designed to simplify the discharge process and improve access to durable medical ...